Loading
Latest filing published 15 Sept 2026 for AstraZeneca PLC, €303k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Michel Demare is known so far (15 September 2026): an open-market purchase, €303k, in AstraZeneca PLC. That is too little to draw conclusions. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration